NCT02541058View on ClinicalTrials.gov

Non-Invasive Chromosomal Evaluation of 22q11.2

CompletedOBSERVATIONAL

Enrollment

420

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

March 17, 2020

Study Completion Date

March 17, 2020

Conditions

22q.11.2 Deletion/Duplication

Trial Locations (1)

1020

The Fetal Medicine Foundation Belgium, Brussles

All Listed Sponsors

lead

Cindy Cisneros

INDUSTRY

NCT02541058 - Non-Invasive Chromosomal Evaluation of 22q11.2 | Biotech Hunter | Biotech Hunter